- Home
- VC vs ARQT Comparison
VC vs ARQT Comparison
Compare VC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VC | ARQT |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United States |
| Employees | 10000 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VC | ARQT |
|---|---|---|
| Price | $112.25 | $25.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $125.50 | $34.00 |
| AVG Volume (30 Days) | 364.9K | ★ 1.5M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | N/A | ★ 88.79 |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $3,768,000,000.00 | $376,072,000.00 |
| Revenue This Year | $2.39 | $34.85 |
| Revenue Next Year | $5.21 | $29.39 |
| P/E Ratio | $97.18 | ★ N/A |
| Revenue Growth | N/A | ★ 91.34 |
| 52 Week Low | $83.49 | $13.06 |
| 52 Week High | $128.32 | $31.77 |
Technical Indicators
Market Signals| Indicator | VC | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 67.98 |
| Support Level | $109.38 | $24.81 |
| Resistance Level | $117.46 | $27.26 |
| Average True Range (ATR) | 4.26 | 1.09 |
| MACD | -1.48 | 0.53 |
| Stochastic Oscillator | 22.08 | 81.29 |
Price Performance
Historical ComparisonAbout VC Visteon Corporation
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.